31 Mar 2023
Assets28.30
Total Income76.07
Profit After Tax7.20
NET Worth11.65
Reserves and Surplus11.63
Total Borrowing0.80
At a glance
Updated 2026-08-24The shares listed at ₹132.50, a 38.02% move from the issue price. Influx Healthtech is a SME IPO with an issue size of ₹58.57 crore, proposed for listing on NSE SME. The offer opens on 18th Jun 2025 and closes on 20th Jun 2025. The issue structure includes a fresh issue of ₹45.07 crore and an offer-for-sale component of ₹10.56 crore. The current listing schedule points to 25th Jun 2025.
Issue details
Listing atNSE SME
Issue typeBook Build Issue
Issue size₹58.57 Cr
Fresh issue₹45.07 Cr
Offer for sale₹10.56 Cr
Face value₹10
Price band₹91.00–₹96.00
Allotment23rd Jun 2025
Listing25th Jun 2025
Listing performance
Full performance ↗Issue price₹96.00
Listing price₹132.50
Current price—
Listing gain38.02%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹20.00
GMP / upper price20.83%
Est. listing₹116.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens18th Jun 2025
Closes20th Jun 2025
Allotment23rd Jun 2025
Refund24th Jun 2025
Demat24th Jun 2025
Listing25th Jun 2025
Subscription demand
Full bidding ↗Total201.35×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 1200 | ₹115,200 |
Company
Use of proceeds
| Object | Amount |
|---|---|
| Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division | ₹22.60 Cr |
| Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division | ₹11.59 Cr |
| Purchase of Machineries for Homecare and Cosmetic Division | ₹2.76 Cr |
| General Corporate Purposes | ₹5.44 Cr |
| Issue Expenses | ₹5.83 Cr |
| Total | ₹48.21 Cr |
Financials
Full financials ↗31 Mar 2024
Assets41.10
Total Income100.10
Profit After Tax11.22
NET Worth22.87
Reserves and Surplus22.85
Total Borrowing0.32
31 Mar 2025
Assets70.30
Total Income104.99
Profit After Tax13.37
NET Worth36.15
Reserves and Surplus18.00
Total Borrowing0.22
Trend chart₹ crore
KPIs
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 36.98% |
| ROCE | 49.17% |
| Debt / Equity | 0.01% |
| RoNW | 36.98% |
| PAT Margin | 12.75% |
| EBITDA Margin | 19.62% |
| Price to Book Value | 4.82 |
Valuation & shareholding
Pre-IPO EPS7.36
Post-IPO EPS5.77
Pre-IPO P/E13.04
Post-IPO P/E16.63
Promoter holding pre99.85%
Promoter holding post73.53%
Market cap₹222.24 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division | ₹22.60 Cr |
| Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division | ₹11.59 Cr |
| Purchase of Machineries for Homecare and Cosmetic Division | ₹2.76 Cr |
| General Corporate Purposes | ₹5.44 Cr |
| Issue Expenses | ₹5.83 Cr |
| Total | ₹48.21 Cr |
Registrar & lead managers
Registrar
Maashitla Securities Pvt.Ltd.Lead managers
- Rarever Financial Advisors Pvt.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-24.